Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.84M | -73.37M | -70.96M | -54.76M | -55.50M |
| Total Depreciation and Amortization | 2.47M | 2.40M | 2.32M | 2.28M | 2.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.69M | 26.43M | 26.64M | 16.72M | 22.70M |
| Change in Net Operating Assets | -10.90M | -12.92M | -14.11M | -12.52M | -9.84M |
| Cash from Operations | -56.58M | -57.46M | -56.10M | -48.27M | -40.34M |
| Capital Expenditure | -3.96M | -4.59M | -3.32M | -3.40M | -3.15M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 50.00K | 50.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -189.17M | -182.78M | -186.92M | -131.00K | -40.33M |
| Cash from Investing | -193.13M | -187.37M | -190.24M | -3.48M | -43.42M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 213.85M | 211.25M | 211.22M | 102.00K | 73.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 59.66M | 59.66M | 59.66M | 59.66M | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.81M | -4.03M | -4.15M | -4.15M | -1.34M |
| Cash from Financing | 270.71M | 266.88M | 266.73M | 55.62M | -1.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.00M | 22.05M | 20.38M | 3.87M | -85.03M |